Search

Author/Creator Hammad, Sherif F.

1. An investigative study of antitumor properties of a novel thiazolo[4, 5-d]pyrimidine small molecule revealing superior antitumor activity with CDK1 selectivity and potent pro-apoptotic properties. Issue 17 (1st September 2020)

Authors:
Mohamed, Sameh H.; Elgiushy, Hossam R.; Taha, Heba; Hammad, Sherif F.; Abou-Taleb, Nageh A.; A. M. Abouzid, Khaled; Al-Sawaf, Hussein; Hassan, Zeinab
Journal:
Bioorganic & medicinal chemistry
Issue:
Volume 28:Issue 17(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Development and validation of a versatile HPLC-DAD method for simultaneous determination of the antiviral drugs daclatasvir, ledipasvir, sofosbuvir and ribavirin in presence of seven potential impurities. Application to assay of dosage forms and dissolution studies. (3rd July 2019)

Authors:
Baker, Mostafa M.; Hammad, Sherif F.; Belal, Tarek S.
Journal:
Drug development and industrial pharmacy
Issue:
Volume 45:Number 7(2019)
Page Start:
1111
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Discovery of novel thiazolyl-pyrazolines as dual EGFR and VEGFR-2 inhibitors endowed with in vitro antitumor activity towards non-small lung cancer. (31st December 2022)

Authors:
Abdelsalam, Esraa A.; Abd El-Hafeez, Amer Ali; Eldehna, Wagdy M.; El Hassab, Mahmoud A.; Marzouk, Hala Mohamed M.; Elaasser, Mahmoud M.; Abou Taleb, Nageh A.; Amin, Kamilia M.; Abdel-Aziz, Hatem A.; Ghosh, Pradipta; Hammad, Sherif F.
Journal:
Journal of enzyme inhibition and medicinal chemistry
Issue:
Volume 37:Number 1(2022)
Page Start:
2265
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗